| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |